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Summary 
Benzidine and its 3,3'-diamino, 3,3'-dimethyl, 3,3'-dimethoxy, 3,3'-difluoro, 3,3'-dichloro, 3,3'-di- 
bromo, 3,3'-dicarbomethoxy and 3,3'-dinitro derivatives together with 2-nitrobenzidine and 3-nitro- 
benzidine were compared for their in vitro and in vivo genotoxicity. Relative mutagenicity was estab- 
lished with Salmonella strains TA98, TA98/1,8-DNP 6 and TA100 with and without $9 activation. All the 
derivatives in the presence of $9 were more mutagenic than benzidine with 3,3'-dinitro- and 3-nitro-ben- 
zidine having the greatest mutagenicity. Mutagenicity in all 3 strains with $9 activation could be 
correlated to electron-withdrawing ability of substituent groups, as measured by the basicity of the 
amines. This correlation was explained on the basis that electron-withdrawing groups could favor the 
stability of the mutagenic intermediate N-hydroxylamine and also enhance the reactivity of the ultimate 
mutagenic species, the nitrenium ion. Mutagenieity was also correlated to the energy of the lowest 
unoccupied molecular orbitals (ELuMO). Hydrophobicity was found to have very limited effect on the 
relative mutagenicity of our benzidine derivatives. The in vivo endpoint was chromosomal aberrations in 
the bone-marrow cells of mice following intraperitoneal administration of benzidine and its derivatives. 
In contrast to the in vitro results, while all the amines were genotoxic in vivo, only the 3-nitro derivative 
had a significant increase in toxicity over benzidine. 
Aromatic amines are widely used industrial 
and laboratory reagents and since it is well estab- 
lished that such compounds can be activated in 
vivo to form DNA adducts, the genotoxicity of 
these amines is of concern (Weisburger and 
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Thorgeirsson, 1981). Thus, there is a growing 
interest in examining quantitative structure-activ- 
ity relationships (QSAR) for the genotoxicity of 
aromatic amines. Most of these QSAR studies 
use Salmonella mutagenicity data as their mea- 
sure of genotoxicity with the objective of develop- 
ing predictive models for in vivo toxicity (Kalopis- 
sis, 1991; Debnath et al., 1992; Ford and Herman, 
1992; Ford and Griffin, 1992). The work of Sab- 
bioni (1992) using hemoglobin binding of mono- 
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cyclic aromatic amines is an extension of in vitro 
QSAR studies to an in vivo model. 
Our interest in structure-activity studies of 
aromatic amines is focused on compounds related 
to the known human carcinogen, benzidine 
(Messerly et al., 1987; Sinsheimer et al., 1992). 
The first of these studies indicated a possible 
correlation between the mutagenicity of benzi- 
dine derivatives and their basicity as affected by 
ortho substitution (Fujita and Nishioka, 1976; Se- 
gura, 1985). The second study showed for benzi- 
dine and 12 related aromatic amines that both 
the electronic effects of substituents and the de- 
gree of conjugation between phenyl rings in a 
compound were major determinants of the in 
vitro Salmonella mutagenicity of these amines, 
but that mutagenicity was not predictive of rela- 
tive in vivo genotoxicity. 
It is the purpose of the present investigation to 
determine quantitatively substituent electronic 
(donating/withdrawing) effects on the muta- 
genicity of benzidine derivatives and their related 
compounds  in Salmonella strains TA98, 
TA98/1,8-DNP 6 and TA100. In addition, it is 
also of interest to examine the correlation of 
mutagenicity with frontier orbital energy (Deb- 
nath et al., 1992; Sabbioni, 1992) as well as hy- 
drophobicity (Debnath et al., 1992) of these com- 
pounds. For the objective of comparing in vitro 
and in vivo genotoxicities, chromosomal aberra- 
tions (CA) in the bone-marrow cells of mice were 
determined following intraperitoneal (i.p.)admin- 
istration of the amines. Test compounds in this 
paper include benzidine and 8 of its 3,3'-dis- 
ubstituted derivatives which were selected to ex- 
amine ortho effects on mutagenicity. 2-Nitro- and 
3-nitro-benzidine were also included in the stud- 
ies for comparison to the genotoxicity of 3,3'-di- 
nitrobenzidine. In a following paper, correlation 
studies of substituent effects on the genotoxicity 
of 4-aminobiphenyl and 4-aminostilbene deriva- 
tives are presented (You et al., 1993). 
Materials and methods 
Test compounds 
Benzidine (92-87-5) was purchased from Har- 
leco, Philadelphia, PA, while 3,3'-dimethoxy- 
benzidine (119-90-4), 3,3'-diaminobenzidine (91- 
95-2) and the positive control, 7,12-dimethyl- 
benz[a]anthracene (DMBA) (57-97-6), were ob- 
tained from Aldrich Chemical Co., Milwaukee, 
WI. 3,3'-Dichlorobenzidine dihydrochloride was 
purchased from Sigma, St. Louis, MO. This salt 
was treated with aqueous sodium hydroxide to 
yield 3,3'-dichlorobenzidine (91-94-1): m.p. 132- 
133°C (Buckingham, 1982: 133°C). 
3,3-Dicarbomethoxybenzidine (15403-45-9) was 
obtained by treatment of benzidine-3,3'-dicarbox- 
ylic acid (Pfaltz and Bauer, Waterbury, CT) in 
refluxing methanol containing concentrated sul- 
furic acid for 2 days. A purified sample (22%, 
green-grey powder) was obtained through crys- 
tallization from ethyl acetate/methanol: m.p. 
211-212°C (Iwakura et al., 1973: 212°C). Proton 
NMR (270 MHz, CDC13): 8.032 (2H, d, J = 2.0 
Hz), 7.492 (2H, dd, J = 8.6, 2.0 Hz), 6.731 (2H, br 
s), 3.908 (6H, s). 
3,3'-Dimethylbenzidine (119-93-7) was prepared 
by reduction of 3,3'-dicarbomethoxybenzidine 
with lithium aluminum hydride (> 10 molar 
equiv.) in refluxing diethyl ether for 1 day. Purifi- 
cation was performed through silica gel column 
chromatography with hexanes/ethyl acetate (2:1) 
as solvent to yield a beige-grey powder (24%): 
m.p. 123.5-125.5°C (Weast and Grasselli, 1989: 
131-132°C). Proton NMR (270 MHz, CDCI3): 
7.242 (2H, s), 7.227 (2H, d, J - -8 .0  Hz), 6.713 
(2H, d, J = 8.0 Hz), 3.606 (4H, br s), 2.220 (6H, s). 
3,3'-Difluorobenzidine (448-97-5) was synthe- 
sized through benzidine rearrangement of 2,2'- 
hydrazine difluorobenzene which in turn was de- 
rived from 2-fluorobenzene (Savard and Josephy, 
1986). It was purified by silica gel column chro- 
matography with hexanes/ethyl acetate (2:1) as 
solvent to give a brownish powder: m.p. 116- 
118°C (Savard and Josephy, 1986: 119-120°C). 
Proton NMR (300 MHz, CDC13): 7.156 (2H, dd, 
J = 12.4, 2.0 Hz), 7.100 (2H, dd, J - -  8.0, 2.0 Hz), 
6.797 (2H, dd, J = 9.2, 8.0 Hz), 3.731 (4H, br s). 
2-Nitrobenzidine (2243-78-9) was obtained by 
treatment of benzidine with nitric acid/sulfuric 
acid (Leslie and Turner, 1933): m.p. 142-143°C 
(Buckingham, 1982: 143°C). Proton NMR (270 
Mnz, CDC13): 7.177 (1H, d, J =  8.3 Hz), 7.061 
(2H, d, J = 8.6 Hz), 7.045 (1H, d, J =  2.5 Hz), 
6.839 (1H, dd, J = 8.3, 2.5 Hz), 6.690 (2H, d, 
J = 8.6 Hz), 3.916 (2H, br s), 3.728 (2H, br s). 
Benzidine was treated with an excess of acetic 
anhydride (15 equiv) and N,N'-diacetylbenzidine 
(white powder) was obtained quantitatively by 
filtration, washing with water and drying under 
vacuum: m.p. 329-332°C (Weast and Grasselli, 
1989: 330-331°C). This product was used to syn- 
thesize the following benzidines. 
3,3'-Dibromobenzidine (34237-98-4) was pre- 
pared from bromination of N,N'-diacetylbenzi- 
dine followed by hydrolysis (Snyder et al., 1949), 
and purified through silica gel chromatography 
with hexanes/ethyl acetate (3:2) to yield a beige 
solid: m.p. 128.5-130.5°C (Savard and Josephy, 
1986: 129-131°C). NMR (300 MHz, CDCI3): 7.565 
(2H, d, J =  2.1 Hz), 7.250 (2H, dd, J =  8.3, 2.1 
Hz), 6.792 (2H, d, J = 8.3 Hz), 4.097 (4H, br s). 
3-Nitrobenzidine (61841-39-2) was prepared by 
treatment of N,N'-diacetylbenzidine with nitric 
acid/acetic acid (Mysyk, 1976) followed by hydro- 
lysis in refluxing aqueous sodium hydroxide. The 
product was purified by silica gel chromatography 
with dichloromethane to yield a red solid: m.p. 
213-214°C (Buckingham, 1982: 215°C). NMR (270 
MHz, CDC13): 8.292 (1H, d, J =  2.2 Hz), 7.593 
(1H, dd, J = 8.6, 2.2 Hz), 7.372 (2H, d, J = 8.5 
Hz), 6.856 (1H, d, J =  8.6 Hz), 6.755 (2H, d, 
J = 8.5 Hz), 6.053 (2H, br s), 3.753 (2H, br s). 
3,3'-Dinitrobenzidine (6271-79-0) was synthe- 
sized by nitration of N,N'-diacetylbenzidine ac- 
cording to the procedure of Barker and Casson 
(1953). The product was recrystallized from pyri- 
dine/ethyl acetate to give red crystals: m.p. 275- 
276°C (Buckingham, 1982: 276°C). NMR (270 
MHz, CDC13): 8.322 (2H, d, J =  2.1 Hz), 7.624 
(2H, dd, J =  8.6, 2.1 Hz), 6.908 (2H, d, J = 8.6 
Hz), 6.146 (4H, br s). 
All test compounds at 0.01 /.~mole showed a 
single spot under UV light on Silica-GF Uni- 
plates (Analtech Inc., Newark, DE) after devel- 
opment with hexanes/ethyl acetate solvent sys- 
tems. This together with the melting point and 
NMR data above as well as the chromatograms 
developed for the determination of partition co- 
efficients indicated that the test compounds were 
of > 98% purity. 
Mutagenicity assays 
Compounds dissolved in DMSO were tested 
for concentration-mutagenicity relationships us- 
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ing Salmonella typhimurium strains TA100 and 
TA98 kindly provided by Dr. B.N. Ames, Univer- 
sity of California, Berkeley as well as strain 
TA98/1,8-DNP 6 kindly provided by Dr. H.S. 
Rosenkranz, University of Pittsburgh. The stan- 
dard plate-incorporation assay with and without 
metabolic activation as described by Maron and 
Ames (1983) was used. Plates were scored with 
an automatic counter (Autocount, Dynatech Labs, 
Chantilly, VA) which had been calibrated against 
manually scored plates. Each dose was run in 
triplicate and the dose-response relationship 
confirmed in a second set of tests. The linear 
range of the dose-response curve for each amine 
was determined using the statistical procedures 
of Bernstein et al. (1982). 
Chromosomal aberrations 
Test chemicals were administered i.p. in 
DMSO (2 ml/kg) as single 100 mg/kg doses to 
each of 4 mice. Negative control mice were in- 
jected with 2 ml/kg DMSO while DMBA was 
used as a positive control at a dose of 100 mg/kg 
in DMSO. The dose for the test compounds is 
based upon our concentration-response data re- 
ported for benzidine (Sinsheimer et al., 1992). 
CA assays were conducted as previously de- 
scribed (Giri et al., 1989) with a scoring time of 
24 h after injection which is consistent with the 
protocol of Preston et al. (1987). This scoring 
time was found to be an optimal time for benzi- 
dine after testing at 6, 12 and 24 h. All the slides 
were coded and observed by a single observer 
where 100 well-spread metaphase cells were 
scored per animal from each of 4 animals at each 
concentration tested. Mitotic indices were calcu- 
lated from 1000 cells/animal and expressed as 
percentages. The aberration frequencies per cell 
for chromatid and chromosome types were calcu- 
lated. Gaps were recorded but not included in 
the frequency of aberrations per ceil. 
Relative partition coefficients 
High-performance liquid chromatography 
(HPLC) was carried out with a C-18 reverse-phase 
column (Partisil PXS 10/25 ODS-3, Whatman, 
Clifton, N J) and solvent mixture of water and 
methanol (45:55 with 0.1% ammonium formate) 
at a flow rate of 1 ml/min. Samples were dis- 
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solved in methanol for injection and all retention 
times were confirmed by a second experiment. 
The partition coefficients were calculated by the 
method of Carlson et al. (1975) using the rela- 
tionship 'fi'HPLC = log k~erivative - l o g  k~enzidin e 
where k '  = (retention time - void volume)/void 
volume. 
Frontier orbital energies 
All calculations were carried out on a Silicon 
Graphics computer with IRIS 4D/360GTX cen- 
tral processor. The compounds were geometry- 
optimized by Q U A N T A  programs with 
CHARMm force field (QUANTA release 3.2, 
Polygen Corp.). These energy-minimized struc- 
tures were then used to calculate the frontier 
orbital energies (EvloM o and ELUMO) through 
PM3 approximation (Steward, 1989a,b) of the 
MOPAC 6.0 package (Quantum Chemistry Pro- 
gram Exchange, Indiana University, Indiana) 
without further geometry-optimization. Each 
compound had at least two conformations with 
energy near the global minimum. Of these con- 
formations, only the frontier orbital energies for 
the structure with the lowest heat of formation 
were taken for the correlations. 
Results and discussion 
In vitro mutagenicity 
The Salmonella mutagenicity results with and 
without $9 activation in strains TA98, TA98/1,8- 
DNP 6 and TA100 for benzidine and its deriva- 
tives are summarized in Table 1. Each of the 
corresponding slopes (revertants//~mole) in Table 
2 were obtained from the linear portion of the 
dose-response curve derived from the data in 
Table 1. As was to be expected, based upon the 
well established metabolic activation of aromatic 
amines to produce DNA alkylating agents (Be- 
land and Kadlubar, 1985, 1990), mutagenicity was 
greater for all compounds in the presence of 
rat-liver $9 fractions than in its absence. How- 
ever, most of the compounds had measurable 
activity without $9 activation in strain TA98 and 
with some of the compounds this was also true in 
strains TA98/1,8-DNP 6 and TA100. The halo- 
genated benzidines had the most pronounced ac- 
tivity without $9 activation in relationship to the 
response following activation. Savard and Jose- 
phy (1986) cited this activity as evidence for mul- 
tiple mechanisms for the genotoxicity of these 
compounds. Even with the halogenated ben- 
zidines, the majority of the mutagenicity resulted 
from amino group activation. 
The results with strain TA98/1,8-DNP6, with 
its absence of O-acetyltransferase (Orr et al., 
1985; Saito et al., 1985), showed reduced muta- 
genicity compared to strain TA98. This decrease 
was not consistent among compounds, with the 
3,3'-dimethoxy derivative and benzidine having 
the greatest percentage loss and 3,3'-dinitro- 
benzidine retaining most of its activity. However, 
the correlation coefficient (r E ) between the log of 
mutagenicity of TA98 and TA98/1,8-DNP 6 for 
the 11 compounds in Table 1 is high (0.92). This 
is also true for the comparison of TA98 to TA100 
(0.83), although in the latter series there were 
lower levels of activity. 
In Table 3 are listed the pKa values of o-sub- 
stituted anilines corresponding to our 3,3'-di- 
substituted benzidines, experimentally derived 
pKa values for some of the test compounds, 
relative partition coefficient (T/'HPLC) values and 
frontier orbital energies (ErtoM o and ELUMO) of 
the benzidine derivatives. The aniline values are 
included as an indication of relative basicity as 
there is only limited basicity data for the ben- 
zidines (Zheltov et al., 1970). We were able to 
measure the pKa values of benzidine and 4 of its 
derivatives by a spectrophotometric method (Al- 
bert and Serjeant, 1984), but the limited solubility 
of 3,3'-diamino-, 3,3'-dicarbomethoxy-, and 3,3'- 
dinitro-benzidine prevented their determination. 
Although the values found for these 5 compounds 
are larger than those of their structurally similar 
anilines, these two measures of basicity data cor- 
relate well (r 2 -- 0.94). 
3-Nitrobenzidine was included in all our muta- 
genicity correlations but 2-nitrobenzidine was not. 
The 2-nitro derivative was excluded since it has a 
different geometry and its conjugation between 
the two phenyl rings is reduced by steric interfer- 
ence of the nitro group. This compound is more 
mutagenic than benzidine which could be ex- 
plained by the electronic effect of the nitro sub- 
stituent counteracting the mutagenicity-reducing 
effect of the loss of conjugation (Messerly et al., 
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T A B L E  1 
M U T A G E N I C I T Y  OF  B E NZ IDINE S  IN Salmonella typhimurium a 
Compounds  TA98 T A98 /1 ,8 -DNP 6 
(/~moles) - $9 + $9 - $9 
Benzidine 
0 2 9 5 : 6  40+  8 415: 8 
0.1 32+ 12 56+  9 36+  6 
0.25 24+ 2 8 7 5 : 1 1  
0.5 2 9 + 1 0  118+ 10 375: 5 
1 2 4 +  6 149+ 32 39+  7 
2.5 29_+ 8 229_+ 19 
5 2 7 5 : 4  3 5 7 5 : 3 5  3 8 5 : 1 2  
10 2 7 5 : 5  472_+ 14 415: 8 
3,3 ' -Diaminobenzidine 
+ $ 9  
60+  12 
485:11 
63+  5 
6 1 + 1 7  








128 + 15 
153 + 23 
1265:11 
1165:15 
+ $ 9  
151 + 15 
1465:23 
183+11 
181 + 30 
2175:31 
258 + 10 
242 5:22 
239 5:25 
0 365: 2 57+  14 30+ 6 36+  7 106+ 8 1295:10 
0.01 42-1- 3 805: 31 285: 7 465:20 915:11 1435:19 
0.05 46+  8 2 2 3 5 : 3 1  305: 9 665:18 9 9 + 1 2  1685:14 
0.1 40+  9 3185: 19 355: 8 124+16 1065:15 209+15  
0.5 505: 9 752+ 61 335: 13 1925: 8 1455:21 293-t-15 
1 55 + 19 948 5:100 33 + 10 285 5:10 180 + 12 346 5:29 
3,3 '-Dimethoxybenzidine 
0 2 9 5 : 8  40+  12 285: 3 40+  8 
0.01 28+11  9 8 5 : 4 0  
0.05 31 5 : 9  195 5 : 2 5  
0.1 3 1 + 1 2  2 7 7 5 : 5 1  29+  6 5 4 5 : 9  
0.2 27+  12 428+ 73 
0.33 365: 4 705:10 
0.4 25 5 : 7  541 + 76 
0.5 555:10 614+ 29 
0.66 39+  6 82+ 15 
0.8 
1 30+  1 6 9 2 5 : 1 5  50+  10 99+31  
3 33 + 7 98 + 22 
104 + 16 
1 2 2 5 : 9  
111 + 16 
1135:15 
119 + 17 





135 + 21 
131 + 6 
146 + 19 
150 + 20 
156 5:12 
182 + 21 
195+11 
192_+29 
207 4- 37 
0 3 1 + 1 7  53+  25 28+  3 40+  8 117+16 126+17 
0.05 27+  6 57+  1 
0.1 20+  7 171+ 9 28+  7 70+  3 92+  5 138+ 4 
0.33 3 7 + 2 4  344+ 44 26+  9 107-/-20 120+18 157+ 7 
0.66 40-[-10 635+ 42 29+  3 160+ 1 106-/- 1 208+25  
1 4 5 + 1 6  957+102  26+  5 272+75  112+24 243+30  
1.5 46 + 17 1392 + 165 103 + 10 278 + 14 













52+  5 
124+ 23 
274 + 21 
437+ 39 
592+ 60 
1350 + 236 
145+ 8 
135 + 1 
139 + 15 
131 + 17 
153 + 16 
144 + 13 
158 + 18 
125+ 7 
136 + 16 
47 + 13 
75+ 37 
81+  28 
151 + 108 
184+ 101 
129+ 57 
33+  7 
40+  5 
47+  8 
104 + 9 
93 + 29 
95 + 33 
113+35 
156 + 15 
201 + 13 
231 + 37 
50 + 10 
66+35  
91 + 24 
126+23 
163 + 22 
353 + 41 
150 + 24 
197 + 23 
198 + 22 
203 5:11 
185 + 10 
230 + 24 
235 + 28 
348 + 46 
394 + 18 
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T A B L E  1 (continued) 
Compounds  
(t~moles) 
TA98 TA98 /1 ,8 -DNP 6 TAIO0 
- $ 9  + $ 9  - $ 9  + $ 9  - $ 9  + $ 9  
3,3'-Dichlorobenzidine 
0 2 5 5 : 6  4 4 5 : 1 7  
0.01 92 5 : 2 9  234 5 : 2 8  
0.02 2 0 3 5 : 8 1  4 8 2 5 : 5 8  
0.03 308 + 29 743 + 102 
0.033 
0.04 297+ 135 1 0 6 9 5 : 8 0  
0.05 158 5: 22 1371 5:103 
0.066 
0.1 223+ 12 
0.2 
0.3 
0.33 360 + 5 
0.66 6 6 4 5 : 1 6  
1 469 + 101 
4 6 5 : 1 7  
140 + 22 
267 5 : 1 0  
529 5 : 2 0  
961 5 : 3 9  
1322+ 76 
1 6 8 5 5 : 8 1  
20+  4 35+  7 
5 5 + 1 0  114+ 41 
114+29 362+ 70 
107+15 117-1- 15 
107 + 14 145 5 : 2 8  
1535:17 676+ 106 109+12 186+ 21 
198-1-92 1142+ 299 116+10 256+ 70 
117+12 388+ 48 
325+55 1626+ 175 116+ 5 509+ 47 
25+  8 32+  5 
38+  3 114+ 7 
136+ 24 153 + 15 
7 1 + 2 6  384+ 28 154+11 206+ 4 
9 8 + 2 9  904+ 163 142+17 202+ 41 
133 + 28 1298 + 161 140 + 21 250 + 62 
156+24 371+ 89 
214 5:49 2113 + 1006 155 + 29 500 5:119 
141+10 683+ 24 
3,3 ' -Dibromobenzidine 
0 26+  5 
0.005 57 + 5 
0.01 59 + 8 
0.02 101 + 27 
0.03 122+ 29 
0.033 
0.04 203 + 83 
0.05 132+ 18 
0.066 
0.1 171 + 10 
0.2 
0.3 
0.33 329_+ 16 
0.5 
0.66 135 + 34 
1 7 3  + 27 
3,3 '-Dicarbomethoxybenzidine 
0 31+  9 
0.005 24 + 8 
0.01 28 + 8 
0.02 25 _+ 7 
0.033 43 + 6 
0.04 30 + 5 
0.06 33 + 9 
0.066 39 + 7 
0.1 51+  7 
0.3 
46+  12 3 4 + 1 2  51+  17 123+25 142+ 26 
175+ 41 32+  6 74+ 10 133+17 165+ 15 
391+ 76 4 0 + 1 0  117+ 21 134+27 166+ 22 
716+ 79 37+  7 166+ 21 117+13 178+ 8 
1369+ 40 29+  9 225+ 29 148+21 189+ 11 
1286+134  4 3 + 1 0  370+ 43 125+10 192+ 27 
1413+ 66 41+  9 331+ 114 103+10 214+ 24 
1713+158  30+  6 400+ 51 135+17 189+ 15 
1602+ 27 22+  9 367+ 43 138+19 166+ 15 
29+  7 239+ 12 
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TABLE 1 (continued) 
Compounds TA98 TA98/1,8-DNP 6 TA100 
(~moles) - $9 + S9 - $9 + $9 - S9 + S9 
3,3'-Dinitrobenzidine 
0 33+ 6 57+ 11 26+ 9 25+ 7 119+ 7 138+ 17 
0.0005 37+ 6 176+ 20 30+ 8 175+ 25 126+10 171+ 19 
0.001 37+ 7 292+ 23 26+ 5 270+ 26 125+18 233+ 53 
0.002 39+ 2 572+ 15 
0.033 30+ 4 979+ 35 32+ 11 862+ 57 1355-30 443+100 
0.004 42+ 5 1279+117 
0.006 46 + 8 2104 5- 126 
0.0066 295- 7 2379+ 88 34+ 11 2163+196 147+17 9165-192 
0.01 41+ 8 35855- 28 34+ 10 30385-377 159+19 1215+289 
0.05 76+ 17 
0.1 88+ 12 
0.5 1625- 17 
1 237+ 31 
3-Nitrobenzidine 
0 36+ 6 49+ 18 29+ 10 36+ 7 116+ 3 1585- 20 
0.0001 1135- 16 
0.00033 255 5- 10 
0.0005 42-1- 1 4165- 16 35-1- 3 715:30 
0.00066 543 5- 15 
0.001 385: 8 8205:73 705- 25 1645:51 2095:20 
0.002 68_+ 4 18914-141 
0.0025 805:38 287_+ 16 
0.003 795: 9 3025:1:91 
0.0033 231 5:11 
0.004 94 5: 6 3524 5:241 
0.005 605- 10 975- 67 7735- 150 
0.0066 341 + 37 
0.01 80 5 :25  205 5-189 1405 5:270 473 ± 28 
0.033 6605- 63 
0.05 2445:15 1625:12 1385:10 
0.1 3515:55 2575:10 1485- 9 
0.33 163 5:17 
0.5 8945-204 7195- 68 
0.66 171 5-16 
1 1645- 8 
2-Nitrobenzidine 
0 235- 9 55_+ 10 235- 5 325- 4 1155:12 130+ 22 
0.01 815:14 325: 8 34-1- 7 
0.05 218± 17 375: 6 545: 2 
0.1 29 5: 4 347 5 :24  455: 9 93 5:23 
0.2 465: 5 6995- 46 126-1-16 2075:19 
0.25 63 5: 6 203± 8 
0.4 445: 7 1617±120 1265-15 2995:42 
0.5 585- 16 20725:93 935- 23 403± 80 
0.6 675:11 24635:220 1325:4 344± 66 
0.8 745:10 1275:11 3445:25 
1 865: 8 160+ 62 8355-107 1495:12 3895:15 
a Combined data from at least two independent experiments, with triplicate plating per dose and at least 5 doses per experiment. 
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TABLE 2 
M U T A G E N I C I T Y  ( R E V E R T A N T S / / z m o l e )  OF BENZIDINES IN Salmonella typhimurium a 
Derivative TA98 TA98/1 ,8-DNP 6 TA100 
- $9 + $9 - $9 + $9 - $9 + $9 
Benzid ine  0 157+ 10 0 4 +  1 
3,3'-Diamino 16+ 5 2681+  149 0 856+ 86 
3,3'-Dimethoxy 0 2905 + 270 21 + 3 54+  8 
3,3'-Dimethyl 11 + 4 927 + 22 0 215 + 15 
3,3'-Difluoro 280+ 38 6709+  305 374+ 65 1095+ 43 
3,3'-Dichloro 7657+852  25592+ 920 2809+297  10945+ 706 
3,3'-Dibromo 4 0 2 4 + 4 3 4  33257+ 743 1061+104 13089+ 511 
3,3'-Dicarbomethoxy 192+ 41 24954+ 1061 0 5333+  382 
3,3'-Dinitro 582+ 49 355967+ 5273 0 309353+8585 
3-Nitro 3 969 + 171 927 423 + 16154 1973 + 578 140 580 + 6 683 
2-Nitro 63_+ 5 4064+  81 132+ 13 807-+ 27 
0 70+  10 
84 + 6 768 + 74 
0 69+  9 
0 104 + 4 
0 232+ 18 
0 1351+ 67 
0 1 102 + 60 
0 1046+ 152 
3753+789  111640+6618 
320+ 52 30079+1558  
25 + 6 365 + 38 
a Values are the calculated slopes ( rev / tzmole)  of the l inear portion of the dose- response  curve derived from the data in Table 1. 
1987; Sinsheimer et al., 1992). The high muta- 
genicity of 3-nitrobenzidine is assumed to be 
caused by activation of the amino group adjacent 
to the nitro substitution with the other amino 
group undergoing much weaker long interactions 
from the nitro group. This assumption is also the 
basis of our utilization of aniline pKa values for 
the relative basicity of the corresponding 3,3'-di- 
substituted benzidines. The large difference be- 
tween a 3- and 3'-substituent in their effects on 
the 4-amino group is illustrated by the pKa val- 
ues of 4-aminobiphenyl (4.05), 4-amino-3-chloro- 
biphenyl (2.76) and 4-amino-3'-chlorobiphenyl 
(3.74) (Byron et al., 1966). Using this approach, 
the basicity of the 4-amino group in 3-nitro- 
benzidine is comparable to that of the 4-amino 
group in 3,3'-dinitrobenzidine. 
Mutagenicity in TA98 with $9 activation corre- 
TABLE 3 
P H Y S I C O C H E M I C A L  P A R A M E T E R S  FO R TH E B E N Z I D I N E  SERIES 
Derivative p K a  a p K a  b EHOM O c ELUM O c ~ HPI..C d 
Benzid ine  4.60 4.80 + 0.08 - 7.607 0.349 0.00 
3,3 ' -Diamino 4.74 - 7.105 0.499 - 0.16 
3,3'-Dimethoxy 4.52 4.70 + 0.07 - 7.483 0.275 0.20 
3,3'-Dimethyl 4.44 5.16 + 0.05 - 7.555 0.381 0.27 
3,3'-Difluoro 3.20 - 7.884 - 0.055 0.21 
3,3'-Dichioro 2.64 3.43 + 0.03 - 7.815 0.048 0.65 
3,3'-Dibromo 2.53 3.19 + 0.06 - 7.864 - 0.095 0.78 
3,3'-Dicarbomethoxy 2.23 - 7.868 - 0.173 0.75 
3,3'-Dinitro - 0.26 - 8.518 - 0.992 0.72 
3-Nitro - 0.26 - 8.004 - 0.737 0.35 
2-Nitro - 7.993 - 0.788 - 0.06 
a Values from corresponding o-substi tuted anil ines (Biggs and Robinson ,  1961; Perrin, 1965). 
b Values determined experimentally by the spectrophotometric  method of Albert  and Serjeant (1984). 
c Frontier  orbital  energies calculated as described in Materials  and methods. 
d Parti t ion coefficients determined by the method of Carlson et al. (1975). 
lated with the basicity of the amines, as measured 
by the pKa values for their corresponding ani- 
lines. 
log (TA98) = -0 .57 pKa  + 5.70 (1) 
n = 10, r 2 = 0.89 
Similar correlations were obtained for strains 
TA98/1,8-DNP 6 and TA100. 
log (TA98/1,8-DNP6) = -0 .72pKa  + 5.35 (2) 
n = 10, r 2 = 0.80 
log (TA100) = -0 .5 3pKa  + 4.48 (3) 
n = 10, r 2= 0.86 
These correlations show a general trend of 
increasing mutagenicity for the benzidine deriva- 
tives with a decrease in their pKa values. Since 
basicity of a substituted aromatic amine must be 
influenced by electron-donating/withdrawing 
ability of its substituent, a relationship between 
mutagenicity and this electronic effect should also 
exist. The effect of ortho-substituents has been 
shown to consist of ordinary electronic, proximity 
electronic and steric effects (Fujita and Nishioka, 
1976; Segura, 1985). When the steric factor is 
negligible, the overall effect of ortho-substituent 
then becomes electronic in nature. This is essen- 
tially true for o-substituted anilines, where steric 
effects accounted for less than 10% of pKa 
change (Fujita and Nishioka, 1976). In this case, 
relative basicity of the anilines reflects relative 
electronic effects of o-substituents. Also, since 
the correlations in their study showed a lack of 
significant hydrogen-bonding disturbance on pKa, 
the basicity data of these anilines should be a 
good approximation of the relative electron- 
withdrawing ability of the o-substituents. Thus 
our correlations show an overall trend of increas- 
ing mutagenicity with an increase in the 
electron-withdrawing ability of the substituents 
ortho to the amino group. The most notable 
deviation from this trend is 3,3'-diaminobenzidine 
whose regioselectivity for enzymatic activation is 
unknown and only assumed to be at the 4-amino 
position. 
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A structure-mutagenicity study on anilines was 
reported recently by Kalopissis (1991), which in- 
cluded basicity as only one of the parameters. 
Our model is different in that we correlate muta- 
genicity using solely the relative basicities of the 
benzidines. While both models depend upon ba- 
sicities, the results are different. For example, we 
can explain the very high mutagenicity of 3,3'-di- 
nitrobenzidine (very low pKa) and the relatively 
low potency of 3,3'-diaminobenzidine (high pKa) 
while the Kalopissis model assigns low mutagenic- 
ity to 2-nitroaniline and very high potency to 
2-aminoaniline. 
An examination of the effect of hydrophobicity 
on mutagenicity shows that there is only a poor 
correlation between the log of mutagenicity and 
rrHPLC values (r 2 = 0.40, 0.42 and 0.26 for TA98, 
TA98/1,8-DNP 6 and TA100 respectively). Also, a 
combination of pKa and ~rHPLC data does not or 
only marginally improves the correlation with mu- 
tagenicity over that with pKa alone. 
Correlation studies of mutagenicity with 
ELUMO give similar results to that with pKa. 
log (TA98) = -2.10ELuMO + 3.97 
n = 1 0 ,  r 2=0.80 
log (TA98/1,8-DNP6) = - 2.60ELuMO + 3.19 
(4) 
(5) 
n = 10, r 2 = 0.70 
log (TA100) = - 1.99ELuMO + 2.87 (6) 
n = 10, r 2 = 0.81 
On the other hand, substantially less correlation 
is obtained for EHOMO (r 2= 0.52, 0.49 and 0.53 
for TA98, TA98/1,8-DNP 6 and TA100 respec- 
tively). A combination of ELUMO and ~'HPLC data 
produces little or marginal improvement over 
ELUMO alone. 
In the established genotoxicity mechanisms for 
aromatic amines (Beland and Kadlubar, 1985; 
1990), the intermediate N-hydroxylamine and ul- 
timate DNA binding species, the nitrenium ion 
(Helmick and Novak, 1991), could serve as the 
basis of our correlations. There have been a 
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number of proposals in this regard based on 
solubility and stability concepts. Debnath et al. 
(1992) stressed the importance of hydrophobicity 
in their Salmonella mutagenicity correlations for 
a large number of compounds of diverse struc- 
tures. Our results, however, for a more closely 
related series of amines showed that mutagenicity 
was highly dependent on the electronic effects of 
benzidine substituents and largely independent of 
the relative partition coefficients of these ben- 
zidines. 
Ford and Herman (1992) found a limited cor- 
relation between Salmonella mutagenicity and the 
stability of the nitrenium ion for some polycyclic 
aromatic amines. The more stable the nitrenium 
ions, the more mutagenic were the corresponding 
aromatic amines. Since electron-withdrawing 
groups which increased the mutagenicity of our 
benzidine derivatives would destabilize the nitre- 
nium ions, this rationale cannot explain our cor- 
relations. 
The stability of the N-hydroxylamines, how- 
ever, may be used to explain our results in a way 
similar to that of Vance et al. (1987) for the 
mutagenicity of 2-nitrofluorene derivatives. N- 
Hydroxylamines are generally unstable species 
with strong lone pair-lone pair electron repulsion 
between the bonding nitrogen and oxygen atoms. 
Electron-withdrawing groups can reduce such re- 
pulsion and help stabilize hydroxylamines, thus 
allowing longer diffusion paths and an increased 
probability of interaction with DNA. Destabiliza- 
tion by electron-withdrawing groups of the nitre- 
nium ions may also increase mutagenicity since 
these ions on one hand should have shorter life 
times, but on the other, should also be more 
reactive toward DNA. 
In vivo genotoxicity 
Benzidine and its derivatives were also com- 
pared for their in vivo genotoxicity where the end 
point was induced chromosomal aberrations in 
T A B L E  4 
IN  V I V O  C H R O M O S O M A L  A B E R R A T I O N S  I N D U C E D  B Y  B E N Z I D I N E S  A T  100 m g / k g  
Der iva t ive  G a p s  a A b e r r a t i o n s / c e l l  A b e r r a n t  cel ls  (%)  b Mi to t ic  indices  (%)  
C h r o m a t i d  C h r o m o s o m e  (mean  ± S.D.) c (mean  ± S.D.) c 
type type 
Solvent  con t ro l  
D M S O  (2 m l / k g )  3.00 0.010 0.000 1.00 +_ 0.82 3.51 + 0.30 
Posi t ive  cont ro l  
D M B A  11.25 0.115 0.023 13.25 _+ 0.96 * * 2.13 + 0.12 * * 
Benz id ine  6.25 0.043 0.080 5.00 + 0.82 * * 2.63 ± 0.33 * * 
3 ,3 ' -D iamino  4.25 0.043 0.000 4.25 + 0.50 * * 2.43 + 0.28 * * 
3 ,3 ' -Dimethoxy  4.25 0.043 0.010 5.25 ± 0.96 * * 2.05 +_ 0.15 * * 
3 ,3 ' -Dimethy l  3.00 0.025 0.008 3.25 + 0.50 * * 2.38 + 0.29 * * 
3 ,3 ' -Di f luoro  2.75 0.023 0.003 2.50 + 0.58 * 2.98 _+ 0.30 * 
3 ,3 ' -Dich loro  4.25 0.028 0.003 3.00 +_ 0.82 * * 2.37 + 0.25 * * 
3 ,3 ' -Dib romo 2.50 0.028 0.000 2.75 + 0.50 * * 3.01 ± 0.35 * 
3 ,3 ' -Dica rbomethoxy  3.50 0.025 0.003 2.75 ± 0.96 * 2.77 ± 0.45 * 
3 ,3 ' -Din i t ro  6.75 0.053 0.005 5.75 ± 0.96 * * 2.14 ± 0.19 * * 
3-Ni t ro  6.50 0.068 0.010 7.75 ± 0.96 * * 2.26 ± 0.24 * * 
2-Ni t ro  5.75 0.065 0.000 6.50 ± 1.00 * * 2.50 ± 0.30 * * 
a Tota l  c h r o m a t i d  and  c h r o m o s o m e  gaps  at  each  concen t r a t i on  pe r  100 cel ls  w e r e  r eco rded  bu t  not  inc luded  as aber ra t ions .  
b Cel ls  wi th  at  l eas t  1 abe r r a t i on  for 4 animals .  
c Resu l t s  w e r e  c o m p a r e d  to  those  of  the control ,  whe re  s ta t i s t ica l ly  s ignif icant  d i f fe rences  a re  ind ica ted  by * P < 0.05 and  
• * P < 0.01 by S tuden t ' s  t test .  
the bone-marrow ceils of mice after i.p. injection 
of the amines. A comparison of the in vivo results 
is summarized in Table 4. At a dose of 100 
mg/kg, a statistically significant increase in geno- 
toxicity was established for all the compounds in 
comparison to the DMSO negative control. How- 
ever, none of the compounds approached the 
genotoxicity of the positive control, DMBA. The 
relative genotoxicity in vivo did not correlate to 
our in vitro mutagenicity data. While the 3,3-di- 
nitro- and 3-nitro-benzidine derivatives were 
again among the most genotoxic, it was only for 
the 3-nitro derivative that a statistically signifi- 
cant increase in genotoxicity over that for benzi- 
dine could be established. In contrast to the in 
vitro results, 2-nitrobenzidine and 3,3'-di- 
methoxybenzidine were among the more geno- 
toxic compounds and the halogenated and car- 
bomethoxy derivatives were significantly less 
genotoxic than benzidine. 
It is of interest that the relative genotoxicity of 
benzidine, which was the least mutagenic com- 
pound in vitro, exhibits genotoxicity generally 
greater or at least equal to the other compounds 
in vivo. This might be explained by the estab- 
lished role of N-acetylation of one amino group 
prior to activation and DNA binding of benzidine 
in vivo (Beland and Kadlubar, 1985, 1990). This 
activation pathway was limited under our in vitro 
conditions (Kennelly et al., 1984). Also, the multi- 
ple metabolic routes for the activation of a hy- 
droxylamine by esterification prior to nitrenium 
ion formation available in vivo (Beland and Kad- 
lubar, 1985) but absent under our in vitro condi- 
tions (Weeks et al., 1978; Wirth and Thorgeirs- 
son, 1980) would contribute to the differences in 
genotoxicity in vivo vs. in vitro. An additional 
potential metabolic activation pathway that could 
play a role in the genotoxicity of benzidine com- 
pounds in vivo but that would be absent under 
our in vitro conditions would be oxidation by 
peroxidase enzymes (Josephy, 1986; Kadlubar et 
al., 1986). Thus, while it is reasonable to assume 
that the substituents have similar effects on the 
stability and activity of N-hydroxylamines as well 
as nitrenium ions in vivo as in vitro, the differ- 
ences between the two systems such as longer 
diffusion paths and different metabolic pathways 
of amine activation and detoxication for in vivo 
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vs. in vitro could account for the differences 
between these two series of genotoxicity results. 
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